Difference spectrophotometric method was developed for the estimation of telmisartan in bulk drug and in pharmaceutical formulations. Telmisartan exists in two different forms in acidic and basic mediums that differ in their UV spectra. Difference spectrum, obtained by keeping telmisartan in 0.01 N NaOH in reference cell and telmisartan in 0.01 N HNO 3 in sample cell, showed two characteristic peaks at 295 nm and 327 nm with positive and negative absorbance respectively. Difference of absorbance between these two maxima was calculated to find out the amplitude, which was plotted against concentration. The method was found to be linear in the range of 2-12 µ µ µ µ µg/ml.
flask and the volume made up with methanol, and filtered through Whatman filter paper. The difference spectrum Helios α double beam recording spectrophotometer with of appropriately diluted acidic and alkaline solutions was 10 mm matched quartz cells was used for the recorded as described above (Table 2 ). determination of absorbance and for recording UV spectra, and Elico pH meter was used for pH Wavelengths of 294 nm and 327 nm were selected for Stock solution of 100 µg/ml in methanol was prepared from standard drug. Suitable samples were taken in 10 ml volumetric flasks and volume made up with 0.01 N HNO 3 and 0.01 N NaOH to prepare a series of standard solutions. Difference spectra were obtained by keeping Wavelength nm previously analyzed sample and then the drug contents were estimated. The study revealed that 100.05±0.72% recovery was obtained.
The proposed method is simple, accurate, precise, sensitive, reproducible and inexpensive and can be potentially applicable for the estimation of telmisartan in tablets.
